Crossmark

Cell state as a design variable in nanomedicine

Crossref DOI link: https://doi.org/10.1038/s41578-026-00932-4

Published Online: 2026-05-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Wenhan

Yu, Weijiang

Ying, Binbin

Wang, Zongjie https://orcid.org/0000-0001-9900-7197
License Information

Text and Data Mining valid from 2026-05-21

Version of Record valid from 2026-05-21
More Information

Article History

First Online: 21 May 2026

Competing interests

: Z.W. is a co-founder and equity holder of CTRL Therapeutics. The other authors declare no competing interests.